Small cell lung cancer (SCLC) is a tough and fast-moving kind of lung cancer. Even with chemo, most patients see their cancer come back quickly, and there haven’t been many big breakthroughs in treatment for years.
Now, a new clinical trial is trying something different: personalizing the fight. Dr. Ward takes samples from each patient’s own cancer and use them to create a custom-made vaccine. This vaccine is designed to teach the immune system exactly what the patient’s cancer looks like, so it can hunt those cells down.
Patients first get regular chemo and a medication called durvalumab, which helps the immune system spot cancer cells. While this is happening, scientists build the patient’s unique vaccine. Once ready, the vaccine is given alongside durvalumab, with the Hope that this one-two punch will help the body attack the cancer more effectively.
This is the only trial right now testing a made-for-you cancer vaccine as a first treatment for SCLC, and researchers are eager to see if it can give patients a real shot at better outcomes.